Clinical Evidence: What Research Shows About GLP-1 Medications and Menstrual Health Clinical trials of semaglutide and tirzepatide reported menstrual irregularities in roughly 515% of female participants, with most cases occurring during the first three months of treatment
The combination increases the risk of serotonin syndrome
Levels decline with age: MOTS-c is higher in younger people and drops over time, which is the core of its longevity rationale
Kasim-Karakas SE, Almario RU, Gregory L, Wong R, Todd H, Lasley BL
"If you believe that you can reach the stars, Wellstar will bring the ladder to help you climb and get up there
doi: 10.3389/fendo.2020.00025 71 MirzaeiRAfaghiABabakhaniSSohrabiMRHosseini-FardSRBabolhavaejiKet al